Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Clene (CLNN) Shares Outstanding (2019 - 2025)

Clene has reported Shares Outstanding over the past 7 years, most recently at $10.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 34.12% year-over-year to $10.8 million; the TTM value through Dec 2025 reached $10.8 million, up 34.12%, while the annual FY2025 figure was $10.8 million, 34.12% up from the prior year.
  • Shares Outstanding for Q4 2025 was $10.8 million at Clene, up from $10.2 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $63.5 million in Q3 2022 and troughed at $3.7 million in Q4 2022.
  • A 5-year average of $26.4 million and a median of $9.1 million in 2025 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: soared 120.66% in 2021 and later plummeted 94.0% in 2022.
  • Year by year, Shares Outstanding stood at $62.3 million in 2021, then plummeted by 94.0% to $3.7 million in 2022, then surged by 71.78% to $6.4 million in 2023, then increased by 25.98% to $8.1 million in 2024, then soared by 34.12% to $10.8 million in 2025.
  • Business Quant data shows Shares Outstanding for CLNN at $10.8 million in Q4 2025, $10.2 million in Q3 2025, and $9.5 million in Q2 2025.